India's Pharmaceutical Exports

Country Profile

Italy

Italy is a significant market for Indian pharmaceutical exports — $243M in FY 2025–26, with 2.8× growth over the past decade. Medicine Ingredients accounts for 42% of shipments, with vaccines contributing $241K. The compound annual growth rate since FY2015 stands at 9.8%.

🇮🇹 $243M · 2.8× growth since FY2015 · 9.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$243M
Exports FY2025–26 DGCIS
2.8×
Growth FY2015→2026
9.8%
CAGR FY2015→2026
42%
Medicine Ingredients Share
5
Product Categories Supplied
Italy is a significant market for Indian pharmaceutical exports — $243M in FY 2025–26, with 2.8× growth over the past decade. Medicine Ingredients accounts for 42% of shipments, with vaccines contributing $241K. The compound annual growth rate since FY2015 stands at 9.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $103M (42.3%) Medicines $89.3M (36.7%) Traditional & Herbal $36.1M (14.8%) Surgical & Hospital Supplies $14.6M (6.0%) Vaccines $241K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Italy in the RBI overseas direct investment dataset (2011–2026).